These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37430466)

  • 1. Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin-2.
    Horie S; Suzuki Y; Yamamoto T; Obika S; Mohri K; Kiyota C; Ren Q; Warashina S; Wada Y; Watanabe Y; Mukai H; Sato Y
    Cancer Sci; 2023 Sep; 114(9):3740-3749. PubMed ID: 37430466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Suzuki Y; Sato Y
    Tohoku J Exp Med; 2024 Mar; 262(3):163-171. PubMed ID: 38220168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2.
    Lee ES; Suzuki Y; Tomioka H; Nakagami H; Sato Y
    Tohoku J Exp Med; 2023 Nov; 261(3):239-247. PubMed ID: 37704418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
    Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
    PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice.
    Prakash TP; Yu J; Kinberger GA; Low A; Jackson M; Rigo F; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3774-3779. PubMed ID: 30342955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
    Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
    Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
    Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
    Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Xue X; Zhang Y; Zhi Q; Tu M; Xu Y; Sun J; Wei J; Lu Z; Miao Y; Gao W
    Cell Commun Signal; 2014 Oct; 12():62. PubMed ID: 25269476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.
    Li Z; Tu M; Han B; Gu Y; Xue X; Sun J; Ge Q; Miao Y; Qian Z; Gao W
    PLoS One; 2014; 9(3):e90358. PubMed ID: 24595063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
    Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
    Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
    Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
    Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Biodistribution and Hepatic Safety Profile of a Gapmer Antisense Oligonucleotide Bearing Guanidine-Bridged Nucleic Acids.
    Sasaki T; Hirakawa Y; Yamairi F; Kurita T; Murahashi K; Nishimura H; Iwazaki N; Yasuhara H; Tateoka T; Ohta T; Obika S; Kotera J
    Nucleic Acid Ther; 2022 Jun; 32(3):177-184. PubMed ID: 35073217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
    Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
    Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.